These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2902381)

  • 1. Envelope cross-reactivity in Western blot for HIV-1 and HIV-2 may not indicate dual infection.
    Tedder RS; O'Connor T; Hughes A; N'jie H; Corrah T; Whittle H
    Lancet; 1988 Oct; 2(8617):927-30. PubMed ID: 2902381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant peptides derived from the env-gene of HIV-2 in the serodiagnosis of HIV-2 infections.
    Schulz TF; Oberhuber W; Hofbauer JM; Hengster P; Larcher C; Gürtler LC; Tedder R; Wachter H; Dierich MP
    AIDS; 1989 Mar; 3(3):165-72. PubMed ID: 2496732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of immunogenic domains in the human immunodeficiency virus type 2 envelope.
    Huang ML; Essex M; Lee TH
    J Virol; 1991 Sep; 65(9):5073-9. PubMed ID: 1714524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-directed enzyme-linked immunosorbent assay with a synthetic simian immunodeficiency virus SIVmac peptide identifying antibodies against the HIV-2 transmembrane glycoprotein.
    Norrby E; Chiodi F; Whalley A; Parks E; Nauclér A; Costa CM; Torstensson R; Biberfeld G
    AIDS; 1989 Jan; 3(1):17-20. PubMed ID: 2469436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Custom-designed synthetic peptide immunoassays for distinguishing HIV type 1 and type 2 infections.
    Gnann JW; Smith LL; Oldstone MB
    Methods Enzymol; 1989; 178():693-714. PubMed ID: 2481220
    [No Abstract]   [Full Text] [Related]  

  • 6. Dual HIV-1 and HIV-2 infection in West Africa supported by synthetic peptide analysis.
    Cot MC; Poulain M; Delagneau JF; Peeters M; Brun-Vezinet F
    AIDS Res Hum Retroviruses; 1988 Aug; 4(4):239-41. PubMed ID: 3207511
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of linear antigenic sites in the envelope proteins of human immunodeficiency virus (HIV) type 2 and type 1.
    Norrby E; Putkonen P; Böttiger B; Utter G; Biberfeld G
    AIDS Res Hum Retroviruses; 1991 Mar; 7(3):279-85. PubMed ID: 1712215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reactivity on western blots in HIV-1 and HIV-2 infections.
    De Cock KM; Porter A; Kouadio J; Maran M; Lafontaine MF; Gershy-Damet GM; Heyward WL; George R
    AIDS; 1991 Jul; 5(7):859-63. PubMed ID: 1892591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for diagnosing HIV-1 infection in atypical Western blots.
    Chen MY; Lee KL; Hung CC; Chuang CY; Chou MJ
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 Aug; 30(3):135-44. PubMed ID: 10592819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of human antibody-binding sites on the external envelope of human immunodeficiency virus type 2.
    de Wolf F; Meloen RH; Bakker M; Barin F; Goudsmit J
    J Gen Virol; 1991 Jun; 72 ( Pt 6)():1261-7. PubMed ID: 1710645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of an atypical HIV type 1 antibody. Serologic pattern leading to detection of HIV type 2 infection in North America.
    Lombardo JM; Horsburgh CR; Denny TN; Michaels J; Schable C; Meyenhofer MF; Shriver K; Sharer LR; Ou CY; Rayfield MA
    Arch Pathol Lab Med; 1989 Nov; 113(11):1245-9. PubMed ID: 2684088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactivity with SIVmac in east African HIV-1-positive sera: evidence against double infection with HIV-1 and a SIVmac/HIV-2-like virus.
    Blomberg J; Klasse PJ; Pehrson C
    Intervirology; 1990; 31(5):276-84. PubMed ID: 1703133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of evidence for HIV-2 infection among at-risk individuals in Brazil.
    Hendry RM; Parks DE; Mello DL; Quinnan GV; Castro BG
    J Acquir Immune Defic Syndr (1988); 1991; 4(6):623-7. PubMed ID: 2023103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrimination of HIV-2 infection from HIV-1 infection by western blot and radioimmunoprecipitation analysis.
    Holzer TJ; Allen RG; Heynen CA; Kennedy MM; Knigge MF; Paul DA; Dawson GJ
    AIDS Res Hum Retroviruses; 1990 Apr; 6(4):515-24. PubMed ID: 2111161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Problems caused by infection due to the HIV retrovirus].
    Brun-Vézinet
    Bull Soc Sci Med Grand Duche Luxemb; 1988; 125(2):35-8. PubMed ID: 2907422
    [No Abstract]   [Full Text] [Related]  

  • 16. New tests produced by Organon Teknika for the diagnosis of antibodies to HIV-1 and HIV-2.
    Chantrain C
    Przegl Epidemiol; 1992; 46(1-2):3-10. PubMed ID: 1475387
    [No Abstract]   [Full Text] [Related]  

  • 17. Laboratory diagnosis of the first cases of HIV-2 infection in Canada.
    Neumann PW; O'Shaughnessy MV; Lepine D; D'Souza I; Major C; McLaughlin B
    CMAJ; 1989 Jan; 140(2):125-8. PubMed ID: 2562925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serologic characterization of human immunodeficiency virus infection by Western blot and radioimmunoprecipitation assays.
    Resnick L; Shapshak P
    Arch Pathol Lab Med; 1987 Nov; 111(11):1040-4. PubMed ID: 3478005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients.
    Loussert-Ajaka I; Ly TD; Chaix ML; Ingrand D; Saragosti S; Couroucé AM; Brun-Vézinet F; Simon F
    Lancet; 1994 Jun; 343(8910):1393-4. PubMed ID: 7910884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited evidence of human immunodeficiency virus type 2 (HIV-2) infection in sera from blood donors showing positive ELISA but negative or indeterminate western blot reactivity for HIV-1 infection.
    Chattopadhya D; Kumari S; Verghese T
    J Commun Dis; 1991 Sep; 23(3):206-7. PubMed ID: 1812169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.